Avexitide (Exendin-3(9-39)amide) is a specific, competitive GLP-1 receptor antagonist (Ki = 0.36 nM). Avexitide binds to the GLP-1 receptor (GLP-1R) with high affinity (Kd = 0.42 nM), blocking the interaction between endogenous GLP-1 and the receptor, thereby counteracting the effects of excessive GLP-1 secretion. Avexitide is being studied for post-bariatric hypoglycemia (PBH) and congenital hyperinsulinism.
Molecular Weight:
3369.76
Purity:
98.00%
CAS Number:
[133514-43-9]
Formula:
C149H234N40O47S
Target:
Glucagon Receptor
TP2100
TP2100
* VAT and and shipping costs not included. Errors and price changes excepted
